Remove Communication Remove Pharmaceutical Manufacturing Remove Workshop
article thumbnail

Pharmaceutical Continuous Manufacturing: Regulatory landscape in the spotlight at USP workshop

Quality Matters

FDA representatives emphasized the agency’s commitment to working with industry to mitigate potential regulatory hurdles to PCM adoption during USP’s workshop on “ Identifying and Addressing Barriers to Continuous Manufacturing Adoption ” July 18-19 in Rockville, Maryland. It is not intended as a comprehensive summary or report.

article thumbnail

Korea’s Minister of Food & Drug Safety: Addressing Medicines Supply Chain Resilience in the Asia-Pacific and Beyond

Quality Matters

Our team is diligent about maintaining consistent communication with manufacturers and other key stakeholders. We prioritize check-ins with stakeholders such as the Association of Medical Doctors and the Association of Pharmaceutical Manufacturers and Distributors regarding any issues with production.